
Sufficient data are not available on the safety and effectiveness of using Meningococcal Group B Vaccine (Bexsero) and other meningococcal group B vaccines interchangeably to complete the vaccination series. Therefore, it is recommended that subjects who receive a first dose of Meningococcal Group B Vaccine (Bexsero) complete the vaccination course with Meningococcal Group B Vaccine (Bexsero).
Method of Administration: The vaccine is given by deep intramuscular injection, preferably in the anterolateral aspect of the thigh in infants or in the deltoid muscle region of the upper arm in older subjects.
Separate injection sites must be used if more than one vaccine is administered at the same time.
For instruction on handling Meningococcal Group B Vaccine (Bexsero) before administration, see Use and Handling under Cautions for Usage.